Background
Infection fatality rate and infection hospitalization rate, defined as the proportion of deaths and hospitalizations, respectively, of the total infected individuals, can estimate the actual toll of COVID-19 on a community as the denominator is ideally based on a representative sample of a population, which captures the full spectrum of illness, including asymptomatic and untested individuals.
Objective
To determine the COVID-19 infection hospitalization rate and infection fatality rate among the non-congregate population in Connecticut between March 1 and June 1, 2020.
Methods
The infection hospitalization rate and infection fatality rate were calculated for adults residing in non-congregate settings in Connecticut before June 2020. Individuals with SARS-CoV-2 antibodies were estimated using the seroprevalence estimates from the recently conducted Post-Infection Prevalence study. Information on total hospitalizations and deaths was obtained from the Connecticut Hospital Association and the Connecticut Department of Public Health.
Results
Before June 1, 2020, nearly 113,515 (90% CI 56,758–170,273) individuals were estimated to have SARS-CoV-2 antibodies and there were 7792 hospitalizations and 1079 deaths among the non-congregate population. The overall COVID-19 infection hospitalization rate and infection fatality rate was 6.86% (90% CI, 4.58%–13.72%) and 0.95% (90% CI, 0.63%–1.90%) and there was variation in these rate estimates across subgroups; older individuals, men, non-Hispanic Black individuals, and those belonging to 2 of the counties had a higher burden of adverse outcomes, though the differences between most subgroups were not statistically significant.
Conclusions
Using representative seroprevalence estimates, the overall COVID-19 infection hospitalization rate and infection fatality rate were estimated to be 6.86% and 0.95%, respectively, among community residents in Connecticut.